Encompass Health/$EHC
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Encompass Health
Encompass Health Corp provides post-acute healthcare services in the United States through a network of inpatient rehabilitation hospitals. Inpatient rehabilitation contributes the majority of the firm's revenue and provides specialized rehabilitative treatment through a network of inpatient hospitals. These hospitals are concentrated in the eastern half of the United States and Texas.
Ticker
$EHC
Sector
Primary listing
NYSE
Industry
Health Care Providers & Services
Headquarters
Employees
28,572
ISIN
US29261A1007
Website
Encompass Health Metrics
BasicAdvanced
$12B
24.87
$4.84
0.79
$0.66
0.56%
Price and volume
Market cap
$12B
Beta
0.79
52-week high
$123.13
52-week low
$82.74
Average daily volume
646K
Dividend rate
$0.66
Financial strength
Current ratio
1.064
Quick ratio
0.84
Long term debt to equity
86.377
Total debt to equity
92.007
Dividend payout ratio (TTM)
13.12%
Interest coverage (TTM)
6.97%
Profitability
EBITDA (TTM)
1,232.5
Gross margin (TTM)
42.05%
Net profit margin (TTM)
8.97%
Operating margin (TTM)
16.95%
Effective tax rate (TTM)
18.96%
Revenue per employee (TTM)
$190,000
Management effectiveness
Return on assets (TTM)
9.07%
Return on equity (TTM)
24.58%
Valuation
Price to earnings (TTM)
24.871
Price to revenue (TTM)
2.186
Price to book
5.63
Price to tangible book (TTM)
20.93
Price to free cash flow (TTM)
31.188
Free cash flow yield (TTM)
3.21%
Free cash flow per share (TTM)
386.11%
Dividend yield (TTM)
0.55%
Forward dividend yield
0.56%
Growth
Revenue change (TTM)
11.21%
Earnings per share change (TTM)
30.44%
3-year revenue growth (CAGR)
12.77%
10-year revenue growth (CAGR)
8.14%
3-year earnings per share growth (CAGR)
7.31%
10-year earnings per share growth (CAGR)
7.95%
3-year dividend per share growth (CAGR)
-16.16%
10-year dividend per share growth (CAGR)
-2.03%
What the Analysts think about Encompass Health
Analyst ratings (Buy, Hold, Sell) for Encompass Health stock.
Bulls say / Bears say
Encompass Health reported a 10.6% increase in revenue to $1.46 billion for Q1 2025, surpassing analyst expectations of $1.43 billion, indicating strong financial performance. (tradingview.com)
The company is expanding its inpatient rehabilitation hospitals, with new facilities opened in Kissimmee, Florida; Atlanta, Georgia; Louisville, Kentucky; Johnston, Rhode Island; and Fort Mill, South Carolina, positioning it for future growth. (tradingview.com)
Goldman Sachs identifies Encompass Health as a long-term AI stock set to rally, highlighting its use of AI to enhance patient care and operational efficiency. (finance.yahoo.com)
Leerink Partners recently cut earnings estimates for Encompass Health, suggesting potential concerns about future profitability. (marketbeat.com)
Insider selling activity, such as CAO Andrew L. Price selling 5,042 shares, may indicate potential concerns about the company's future performance. (defenseworld.net)
The company's debt-to-equity ratio of 0.88 could pose financial risks, especially in a rising interest rate environment. (marketbeat.com)
Data summarised monthly by Lightyear AI. Last updated on 6 Jun 2025.
Encompass Health Financial Performance
Revenues and expenses
Encompass Health Earnings Performance
Company profitability
Encompass Health News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
Jul15
Encompass Health
Dividend·Payment
$0.17Per share
FAQs
What’s the current market cap for Encompass Health stock?
Encompass Health (EHC) has a market cap of $12B as of July 03, 2025.
What is the P/E ratio for Encompass Health stock?
The price to earnings (P/E) ratio for Encompass Health (EHC) stock is 24.87 as of July 03, 2025.
Does Encompass Health stock pay dividends?
Yes, the Encompass Health (EHC) stock pays dividends to shareholders. As of July 03, 2025, the dividend rate is $0.66 and the yield is 0.56%. Encompass Health has a payout ratio of 13.12% on a trailing twelve-month basis.
When is the next Encompass Health dividend payment date?
The next Encompass Health (EHC) dividend payment is scheduled for July 15, 2025.
What is the beta indicator for Encompass Health?
Encompass Health (EHC) has a beta rating of 0.79. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.